Home » Topics » Conferences

Conferences
RSS

Potent TNF inhibitor described by Celgene

April 28, 1997

Potential new treatments highlighted at recent periodontology symposium

April 28, 1997

Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck

April 28, 1997

Glaxo Wellcome discovers potent BAT inhibitor

April 28, 1997

Potent, selective beta3-agonist from Merck & Co.

April 25, 1997

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

Novel marine antioxidant described by UNC researchers

April 25, 1997

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

CoCensys discovers potent, water-soluble allosteric modulators of GABA-A receptor

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...